Clinical Trial Update: Roxadustat in the Treatment of Anemia in End Stage Renal Disease (ESRD) Patients on Stable Dialysis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating roxadustat for anemia in end-stage renal disease patients on stable dialysis has completed, with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• End-stage Renal Disease

Drugs mentioned

• Roxadustat (roxadustat)

Snippet

Sponsor: Astellas Pharma Europe B.V. | Conditions: Anemia, End Stage Renal Disease (ESRD) | Phase 3 | Status: COMPLETED | Results posted: 2020-08-26